Back to Rankings

VTVT

vTv TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
VTVT vs peer average
70/100
VTVT vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

MXCT is the first available peer comparator.

Adjacency comp by size more than program similarity; useful as a reminder that sub-$200 million life-science companies can trade heavily on partnership, funding, and execution milestones.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMXCTMaxCyte
VTVT
vTv Therapeutics
MXCT
MaxCyte
Grade
B
F
Momentum
83
19
Value
41
41
Sentiment
46
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs MXCT

VTVT / MXCT
Grade Position
Above peers
VTVT vs. peer average (B vs. C)
70/100
Momentum
83
VTVT
Value
41
VTVT
Sentiment
46
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VTVT
1
MXCT
MXCT
F
20/100
+3
2
RANI
RANI
B
80/100
Even
3
SRZN
SRZN
B
80/100
Even
4
RCEL
AVITA Medical Inc Common
F
20/100
+3
5
CRDL
Cardiol Therapeutics Inc Class A Common
A
100/100
-1
MXCT is the first peer returned for this comparison set.